The Emerging Role of DNA Damage in the Pathogenesis of the C9orf72 Repeat Expansion in Amyotrophic Lateral Sclerosis
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Amyotrophic lateral sclerosis (ALS) is a fatal, rapidly progressing neurodegenerative disease affecting motor neurons, and frontotemporal dementia (FTD) is a behavioural disorder resulting in early-onset dementia. Hexanucleotide (G4C2) repeat expansions in the gene encoding chromosome 9 open reading frame 72 () are the major cause of familial forms of both ALS (~40%) and FTD (~20%) worldwide. The C9orf72 repeat expansion is known to form abnormal nuclei acid structures, such as hairpins, G-quadruplexes, and R-loops, which are increasingly associated with human diseases involving microsatellite repeats. These configurations form during normal cellular processes, but if they persist they also damage DNA, and hence are a serious threat to genome integrity. It is unclear how the repeat expansion in causes ALS, but recent evidence implicates DNA damage in neurodegeneration. This may arise from abnormal nucleic acid structures, the greatly expanded C9orf72 RNA, or by repeat-associated non-ATG (RAN) translation, which generates toxic dipeptide repeat proteins. In this review, we detail recent advances implicating DNA damage in C9orf72-ALS. Furthermore, we also discuss increasing evidence that targeting these aberrant confirmations may have therapeutic value for ALS, thus revealing new avenues for drug discovery for this disorder.
Mechanisms underlining R-loop biology and implications for human disease.
Liu J, Li F, Cao Y, Lv Y, Lei K, Tu Z Front Cell Dev Biol. 2025; 13:1537731.
PMID: 40061014 PMC: 11885306. DOI: 10.3389/fcell.2025.1537731.
Proteins Associated with Neurodegenerative Diseases: Link to DNA Repair.
Khodyreva S, Dyrkheeva N, Lavrik O Biomedicines. 2025; 12(12.
PMID: 39767715 PMC: 11673744. DOI: 10.3390/biomedicines12122808.
repeat expansion creates the unstable folate-sensitive fragile site FRA9A.
Mirceta M, Schmidt M, Shum N, Prasolava T, Meikle B, Lanni S NAR Mol Med. 2024; 1(4):ugae019.
PMID: 39669124 PMC: 11632612. DOI: 10.1093/narmme/ugae019.
Dashtmian A, Darvishi F, Arnold W Cells. 2024; 13(11.
PMID: 38891059 PMC: 11171952. DOI: 10.3390/cells13110928.
Senataxin deficiency disrupts proteostasis through nucleolar ncRNA-driven protein aggregation.
Wen X, Xu H, Woolley P, Conway O, Yao J, Matouschek A J Cell Biol. 2024; 223(7).
PMID: 38717338 PMC: 11080644. DOI: 10.1083/jcb.202309036.